PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Dalteparin sodium - VTE prophylaxis
PAD Profile : Dalteparin sodium - VTE prophylaxis
Keywords :
Venous Thromboembolism, Low molecular weight heparins, LMWH, SWLEOC guidelines
Brand Names Include :
Fragmin
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
- Pre-operative / bridging therapy
- VTE prevention post hip/knee replacement
- VTE treatment in patients unable to take oral anticoagulants
- VTE treatment in pregnancy
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
24 October 2007
Not Set
The prophylaxis use of LMWH in patients is considered as green on the traffic light system e.g. for high risk patients flying
Associated BNF Codes
02. Cardiovascular System
02.08.01. Parenteral anticoagulants